Original Article
You have full text access to this OnlineOpen article
Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population
Article first published online: 13 MAR 2008
DOI: 10.1002/ibd.20399
Copyright © 2008 Crohn's & Colitis Foundation of America, Inc.
Additional Information
How to Cite
Tremelling, M., Berzuini, C., Massey, D., Bredin, F., Price, C., Dawson, C., Bingham, S. A. and Parkes, M. (2008), Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis, 14: 733–737. doi: 10.1002/ibd.20399
Publication History
- Issue published online: 5 MAY 2008
- Article first published online: 13 MAR 2008
- Manuscript Accepted: 2 JAN 2008
- Manuscript Received: 27 DEC 2007
Funded by
- Clinical Research Training Fellowship from the Wellcome Trust
- National Association for Colitis and Crohn's Disease
REFERENCES
- 1, , , et al. Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. J Immunol. 2003; 171: 4868–4874.
- 2, , , et al. Dominant role for TL1A/DR3 pathway in IL-12 plus IL-18-induced IFN-gamma production by peripheral blood and mucosal CCR9+ T lymphocytes. J Immunol. 2005; 174: 4985–4990.
- 3, , , et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet. 2005; 14: 3499–3506.
- 4, , , et al. Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease. Gut. 2006; 55: 1527–1528.
- 5, , , et al. TNFSF15 is an ethnic-specific IBD gene. Inflamm Bowel Dis. 2007; 13: 1333–1338.
- 6, , , et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet. 2003; 33: 177–182.
- 7, , , et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004; 99: 2393–2404.Direct Link:
- 8, , , et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002; 47: 469–472.
- 9. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989; 170: 2–6.
- 10, , , et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19( suppl A): 5–36.
- 11The International Hapmap Consortium. A haplotype map of the human genome. Nature. 2005; 437: 1299–320.
- 12, , , et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007; 39: 207–211.
- 13, , , et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314: 1461–1463.
- 14, , , et al. IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease. Gastroenterology. 2007; 132: 1657–1664.
- 15, , , et al. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet. 2002; 11: 1281–1289.
- 16, , , et al. Replication of association between IBD and TNF-857 but not DLG5. Inflamm Bowel Dis. 2006; 12: 178–184.
- 17, , , et al. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet. 2005; 6: 109–118.
- 18, , , et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity. 2002; 16: 479–492.
- 19, , , et al. A “silent” polymorphism in the MDR1 gene changes substrate specificity. Science. 2007; 315: 525–528.

1536-4844/asset/IBD_left.gif?v=1&s=9aca2b5041534c51cac4bb66560294c77a457a07)
1536-4844/asset/IBD_right.gif?v=1&s=402e3e241083497ae622916e85e47f64138255a4)
